Drugs in Dev.
Dermatology
Undisclosed
Sweden 
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Cannabidiol
Therapeutic Area : Dermatology
Study Phase : Undisclosed
Sponsor : Cannassure Therapeutics
Deal Size : $0.4 million
Deal Type : Licensing Agreement
Details : Under the agreement, Cannassure has the exclusive right to use Lipidor’s proprietary drug delivery technology AKVANO®in medicinal cannabis products for the treatment of selected indications such as psoriasis, atopic dermatitis, pain and lesions.
Product Name : Undisclosed
Product Type : Controlled Substance
Upfront Cash : Undisclosed
January 18, 2021
Lead Product(s) : Cannabidiol
Therapeutic Area : Dermatology
Highest Development Status : Undisclosed
Sponsor : Cannassure Therapeutics
Deal Size : $0.4 million
Deal Type : Licensing Agreement
